Axcella Health Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2015-05-28. The offering totals $39.3M, of which $39.3M was reported sold. Industry: Biotechnology.
Showing 25 of 28 people.
| Name | Role | Location |
|---|---|---|
| Glenn Barton Nedwin | Director | CAMBRIDGE, MA |
| William Hinshaw | Director | Philadelphia, PA |
| William Hinshaw | Executive Officer | Philadelphia, PA |
| David Berry | Director | Cambridge, MA |
| Robert Connelly | Director | Boston, MA |
| Robert Connelly | Executive Officer | Boston, MA |
| Peter Barton Hutt | Director | Salt Lake City, UT |
| Paul D Sekhri | Director | Cambridge, MA |
| Martin D Hendrix | Director | Cambridge, MA |
| Cristina M Rondinone | Director | Cambridge, MA |
| Margaret Koziel | Executive Officer | Cambridge, MA |
| Virginia Dean | Executive Officer | Cambridge, MA |
| Gary D Pisano | Director | Cambridge, MA |
| David R Epstein | Director | Cambridge, MA |
| Robert Crane | Executive Officer | Cambridge, MA |
| Catherine A Sohn | Director | Cambridge, MA |
| William D Baird | Director | Cambridge, MA |
| Paul Fehlner | Executive Officer | Cambridge, MA |
| Michael D Rosenblatt | Director | Cambridge, MA |
| Charles Cooney | Director | Cambridge, MA |
| GREGORY BEHAR | Director | SAN DIEGO, CA |
| Noubar Afeyan | Director | Cambridge, MA |
| John Barton Mendlein | Director | CAMBRIDGE, MA |
| Stephen Hoge | Director | CAMBRIDGE, MA |
| Gary Barton Pisano | Director | CAMBRIDGE, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2022-09-23 | D | $12.0M | $6.0M |
| 2017-02-24 | D/A | — | $42.5M |
| 2016-02-24 | D | $42.5M | $42.5M |
| 2016-02-24 | D/A | — | $44.3M |
| 2015-09-15 | D/A | — | $39.3M |
| 2015-02-17 | D | $28.3M | $28.3M |